Alejandro Teper

1.9k total citations
64 papers, 1.0k citations indexed

About

Alejandro Teper is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Alejandro Teper has authored 64 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 24 papers in Physiology and 22 papers in Surgery. Recurrent topics in Alejandro Teper's work include Asthma and respiratory diseases (24 papers), Neonatal Respiratory Health Research (17 papers) and Cystic Fibrosis Research Advances (13 papers). Alejandro Teper is often cited by papers focused on Asthma and respiratory diseases (24 papers), Neonatal Respiratory Health Research (17 papers) and Cystic Fibrosis Research Advances (13 papers). Alejandro Teper collaborates with scholars based in Argentina, United States and Canada. Alejandro Teper's co-authors include Alejandro Colom, Alberto Maffey, Santiago Vidaurreta, Gilberto Bueno Fischer, Facundo García‐Bournissen, M. J. Gaillard, Ron G. Rosenfeld, Alan M. Krensky, Juan J. Heinrich and Vivian Hwa and has published in prestigious journals such as Blood, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Alejandro Teper

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alejandro Teper Argentina 16 634 404 226 209 177 64 1.0k
Jihong Dai China 17 352 0.6× 151 0.4× 187 0.8× 140 0.7× 75 0.4× 62 794
Nikhil Amin United States 15 458 0.7× 361 0.9× 49 0.2× 252 1.2× 196 1.1× 37 965
Young-Joo Cho South Korea 19 356 0.6× 511 1.3× 67 0.3× 144 0.7× 186 1.1× 63 993
Michael J. Boyle Australia 10 881 1.4× 1.2k 2.9× 164 0.7× 229 1.1× 464 2.6× 15 1.6k
Heidi Makrinioti United Kingdom 15 280 0.4× 369 0.9× 185 0.8× 94 0.4× 295 1.7× 40 946
P Tukiainen Finland 18 753 1.2× 367 0.9× 322 1.4× 142 0.7× 21 0.1× 55 1.1k
Peter H. Michelson United States 14 284 0.4× 108 0.3× 119 0.5× 172 0.8× 25 0.1× 18 636
Jeffrey Jacobs United States 12 124 0.2× 170 0.4× 77 0.3× 98 0.5× 43 0.2× 28 602
Yutaka Matsubara Japan 13 212 0.3× 131 0.3× 139 0.6× 278 1.3× 44 0.2× 64 672
Amit Parulekar United States 15 327 0.5× 363 0.9× 53 0.2× 202 1.0× 135 0.8× 35 700

Countries citing papers authored by Alejandro Teper

Since Specialization
Citations

This map shows the geographic impact of Alejandro Teper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Teper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Teper more than expected).

Fields of papers citing papers by Alejandro Teper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Teper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Teper. The network helps show where Alejandro Teper may publish in the future.

Co-authorship network of co-authors of Alejandro Teper

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Teper. A scholar is included among the top collaborators of Alejandro Teper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Teper. Alejandro Teper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teper, Alejandro, Alejandro Colom, Ralf Schubert, & Silvija‐Pera Jerkic. (2023). Update in postinfectious bronchiolitis obliterans. Pediatric Pulmonology. 59(9). 2338–2348. 7 indexed citations
2.
3.
Balinotti, Juan E., et al.. (2019). Course of lung function in children with cystic fibrosis in their first 3 years of life. Archivos Argentinos de Pediatria. 117(5). 323–329.
4.
Buendía, Jefferson Antonio, et al.. (2019). Risk factors associated with pulmonary exacerbations in pediatric patients with cystic fibrosis. Archivos Argentinos de Pediatria. 117(5). e466–e472. 2 indexed citations
5.
Wenzel, Sally E., Ian Pavord, Jaman Maroni, et al.. (2018). Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST. American Journal of Respiratory and Critical Care Medicine. 197. 12 indexed citations
6.
Teper, Alejandro, et al.. (2017). Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Cystic Fibrosis Patients from Argentina. Microbial Drug Resistance. 24(5). 613–620. 8 indexed citations
7.
Ren, Clement L., Charles R. Esther, Jason S. Debley, et al.. (2016). Official American Thoracic Society Clinical Practice Guidelines: Diagnostic Evaluation of Infants with Recurrent or Persistent Wheezing. American Journal of Respiratory and Critical Care Medicine. 194(3). 356–373. 34 indexed citations
8.
Baldoni, Monia, et al.. (2012). 189 Airway clearance techniques currently used in a cystic fibrosis center in Argentina. Journal of Cystic Fibrosis. 11. S105–S105. 1 indexed citations
9.
Teper, Alejandro, Anna Jaques, & Brett Charlton. (2010). Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial. Journal of Cystic Fibrosis. 10(1). 1–8. 39 indexed citations
10.
Teper, Alejandro, et al.. (2006). Respuesta broncodilatadora al salbutamol administrado como aerosol presurizado mediante aerocámaras con válvulas o espaciadores no valvulados. Archivos Argentinos de Pediatria. 104(2). 176–182. 2 indexed citations
11.
Cohen, Aileen Cleary, Kari C. Nadeau, Wenwei Tu, et al.. (2006). Cutting Edge: Decreased Accumulation and Regulatory Function of CD4+CD25high T Cells in Human STAT5b Deficiency. The Journal of Immunology. 177(5). 2770–2774. 178 indexed citations
12.
Ferguson, Alexander C., et al.. (2006). A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma. Respiratory Medicine. 101(1). 118–129. 23 indexed citations
13.
Teper, Alejandro, et al.. (2005). Inhaled Corticosteroids in Wheezy Infants. American Journal of Respiratory and Critical Care Medicine. 172(8). 1059–1059.
14.
Teper, Alejandro, et al.. (2005). Fluticasone Improves Pulmonary Function in Children under 2 Years Old with Risk Factors for Asthma. American Journal of Respiratory and Critical Care Medicine. 171(6). 587–590. 53 indexed citations
15.
Teper, Alejandro, et al.. (2004). Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing. Pediatric Pulmonology. 37(2). 111–115. 41 indexed citations
16.
Teper, Alejandro, Gilberto Bueno Fischer, & Marcus Herbert Jones. (2002). Respiratory sequelae of viral diseases: from diagnosis to treatment. Jornal de Pediatria. 78(8). 187–94. 12 indexed citations
17.
Fischer, Gilberto Bueno, Alejandro Teper, & Alejandro Colom. (2002). Acute viral bronchiolitis and its sequelae in developing countries. Paediatric Respiratory Reviews. 3(4). 298–302. 25 indexed citations
18.
Cicco, Maria Di, et al.. (2001). Effects of 2 Inhaled Corticosteroids on Growth. Archives of Pediatrics and Adolescent Medicine. 155(11). 1248–54. 39 indexed citations
19.
Simons, F. Estelle R., Alejandro Teper, Gustavo Aristizábal, et al.. (2001). Montelukast added to budesonide in children with persistent asthma: A randomized, double-blind, crossover study. The Journal of Pediatrics. 138(5). 694–698. 131 indexed citations
20.
Teper, Alejandro, et al.. (1999). Lung function in infants with chronic pulmonary disease after severe adenoviral illness. The Journal of Pediatrics. 134(6). 730–733. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026